ANN ARBOR, Mich., Dec. 13, 2022 (GLOBE NEWSWIRE) -- Esperion (NASDAQ:ESPR) announced today that the Company plans to present at the J.P. Morgan 41^st Annual Healthcare Conference as well as the LifeSci Partners 12^th Annual Corporate Access Event. Both in-person events are taking place January 9-11^th, 2023 in San Francisco, California.

J.P. Morgan 41^st Annual Healthcare Conference

Sheldon Koenig, CEO, will be making a corporate presentation and hosting 1x1 institutional investor meetings.

Date/Time: January 11^th, 2023, 1:30pm PT

Location: The Westin St. Francis Hotel in San Francisco; Georgian Room

Click here to access the webcast.

LifeSci Partners 12^th Annual Corporate Access Event

Sheldon Koenig, CEO, Ben Halladay, CFO, and JoAnne Foody, CMO, will be hosting 1x1 institutional investor meetings.

Date/Time: January 9-10^th, 2023

Location: Beacon Grand Hotel in San Francisco

To schedule a meeting on the online system managed by LifeSci Partners, please click here to register for the conference.

Esperion Therapeutics

Esperion works hard to make our medicines easy to get, easy to take, and easy to have. We discover, develop, and commercialize innovative medicines and combinations to lower cholesterol, especially for patients whose needs aren't being met by the status quo. Our entrepreneurial team of industry leaders is inclusive, passionate and resourceful. We are singularly focused on managing cholesterol so you can improve your health easily. For more information, please visit www.esperion.com and follow us on Twitter at www.twitter.com/EsperionInc.

Contact:

Esperion Corporate Communications

corporateteam@esperion.com